CMB 4.76% 40.0¢ cambium bio limited

Ann: Regeneus signs MOU with Kyocera Corporation, page-20

  1. 172 Posts.
    lightbulb Created with Sketch. 52
    So this misleading info comes from Finfeed then... because in the original paper refered to, no mention of Progenza or any anti-inflammatory treatment.
    https://www.sciencedirect.com/science/article/pii/S0140673620303007

    This doesn't mean Progenza is not suited for ARDS, but it's far from becoming a treatment for Covid.

 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.020(4.76%)
Mkt cap ! $4.772M
Open High Low Value Volume
42.0¢ 42.0¢ 40.0¢ $2.069K 5.062K

Buyers (Bids)

No. Vol. Price($)
2 8915 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 1910 1
View Market Depth
Last trade - 10.11am 29/07/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.